FDA Cites mkpodplug.co.uk in 2026-07-17 Warning Letter — Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
Letter issued · posted to fda.gov .
Subject as published: Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded
TL;DR
Here's the summary: On July 17, 2026, the FDA Center for Tobacco Products issued a warning letter to mkpodplug.co.uk (Reference #RW2602434) regarding nicotine pouch products sold through its website to U.S. consumers. The FDA determined that the "Greatest Cold Dry – 16mg" nicotine pouch product was misbranded under the Federal Food, Drug, and Cosmetic Act because it was sold to a person under 21 years of age during an FDA investigation. The agency requested written response within 15 working days detailing corrective actions and compliance plans, warning that failure to address violations may result in civil penalties, seizure, and/or injunction.
Argus analysis
# FDA Warning Letter Analysis: mkpodplug.co.uk
**Company and Violations**
The FDA Center for Tobacco Products issued a warning letter to mkpodplug.co.uk on July 17, 2026, regarding the sale of nicotine pouch products through its website. The agency determined that the company sold its "Greatest Cold Dry – 16mg" nicotine pouch product to a person under 21 years of age. Under the Family Smoking Prevention and Tobacco Control Act, nicotine pouches qualify as tobacco products regardless of whether they derive from tobacco, triggering FDA jurisdiction and associated compliance obligations.
**Regulatory Citations and Meaning**
The warning cites section 906(d)(5) of the FD&C Act, which prohibits any retailer from selling tobacco products to persons under 21. The agency also cited section 903(a)(7)(B), which designates such sales as "misbranding." These provisions are implemented through 21 CFR Parts 1140, 1141, and 1143. The citations reflect established minimum-age restrictions; their invocation signals that mkpodplug.co.uk failed to maintain age-verification systems during the online purchase transaction that FDA investigators conducted.
**Response Timeline and Industry Monitoring**
The company must submit a written response within 15 working days explaining corrective actions and compliance plans. The letter warns of potential regulatory consequences, including civil penalties, product seizure, and injunctions. Compliance officers in e-commerce tobacco retail should monitor whether mkpodplug.co.uk implements age-verification technology, updates payment processing protocols, or modifies shipping practices. The inclusion of Shopify and Instra Corporation (domain registrar) as letter recipients suggests the FDA expects platform cooperation in enforcing age restrictions on third-party vendors.
Severity context
Critical severity. Typically reserved for data integrity, sterile-product CGMP, or repeat violations — matters that historically precede injunctions, consent decrees, or import alerts.
Regulatory background
Tobacco letters cite the Family Smoking Prevention and Tobacco Control Act, primarily Section 910 (premarket review of new tobacco products) for ENDS / e-vapor SKUs.
What peer compliance teams typically do next
Most compliance officers at peer companies use a Warning Letter against a named entity as a checklist for their own CAPA program. Common steps: pull the verbatim FDA letter; map each cited 21 CFR section against the team’s SOP library; confirm CAPA coverage; brief the QMR (Quality Management Review) on whether the cited subject matter is in scope for the next internal audit. The 15-business-day response window applies to the cited entity, not to peers — but a documented internal review against the cited subjects is what regulators expect to see if a peer is later inspected on the same topic.
Excerpt from the FDA Warning Letter (public domain, 17 USC §105)
WARNING LETTER mkpodplug.co.uk MARCS-CMS 734448 — July 17, 2026 More Warning Letters Warning Letters About Warning and Close-Out Letters Delivery Method: VIA Electronic Mail Reference #: RW2602434 Product: Tobacco Recipient: mkpodplug.co.uk United States info@mkpodplug.co.uk Podplug@mkpodplug.co.uk Issuing Office: Center for Tobacco Products United States July 17, 2026 WARNING LETTER To Whom It May Concern: The Center for Tobacco Products of the U.S. Food and Drug Administration (FDA) recently reviewed the website https://mkpodplug.co.uk and determined that nicotine pouch products listed there are offered for sale or distribution to consumers in the United States. Under section 201(rr) of the Federal Food, Drug, and Cosmetic Act (FD&C Act) (21 U.S.C. § 321(rr)), these products are tobacco products because they are made or derived from tobacco or contain nicotine from any source, and are intended for human consumption. 1 Certain tobacco products, including nicotine pouch products, are subject to FDA jurisdiction under section 901 of the FD&C Act (21 U.S.C. § 387a) and 21 C.F.R. § 1100.1, and are required to be in compliance with the requirements in the FD&C Act. Under section 906(d)(5) of the FD&C Act (21 U.S.C. § 387f(d)(5)), it is unlawful for any retailer 2 to sell a tobacco product to any person younger than 21 years of age. 3 This includes tobacco products containing nicotine from any source including cigarettes, smokeless tobacco, cigars, e-cigarettes, and nicotine pouches. Tobacco Product Sold by a Retailer to an Individual Under the Age of 21 is Misbranded Under section 903(a)(7)(B) of the FD&C Act (21 U.S.C. § 387c(a)(7)(B)), tobacco products are misbranded if sold or distributed by any retailer to a person younger than 21 years of age in violation of section 906(d)(5) of the FD&C Act (21 U.S.C. § 387f(d)(5)). FDA has determined that your Greatest Cold Dry – 16mg nicotine pouch product is misbranded under section 903(a)(7)(B) of the FD&C Act (21 U.S.C. § 387c(a)(7)(B)) because this product was sold to a person younger than 21 years of age. Specifically, during FDA’s investigation of https://mkpodplug.co.uk, a person younger than 21 years of age purchased Greatest Cold Dry – 16mg nicotine pouch product from your website. Conclusion and Requested Actions It is your responsibility to ensure that your tobacco products and all related labeling and/or advertising on this website, on any other websites (including e-commerce, social networking, or search engine websites), in any other media in which you advertise, and in any retail establishments comply with each applicable provision of the FD&C Act and FDA’s implementing regulations. Failure to address any violations of the FD&C Act, 21 U.S.C. § 301 et seq., and FDA’s implementing regulations, including those in 21 C.F.R. Parts 1140, 1141, and 1143, may lead to regulatory action, including, but not limited to, civil money penalties, seizure, and/or injunction. Please note that tobacco products o…
Excerpt only. The full verbatim Warning Letter is the source of truth — always read the original before regulatory decisions.
The verbatim FDA Warning Letter is the source of truth. Always read the original before acting on any analysis or summary on this page.
Read the full letter on fda.gov ↗Frequently asked questions
- What FDA violations was mkpodplug.co.uk cited for?
- The FDA Warning Letter to mkpodplug.co.uk (issuing office: Center for Tobacco Products) cites: Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded. Classification: Tobacco / ENDS.
- When did FDA issue the warning letter to mkpodplug.co.uk?
- FDA issued the letter (MARCS-CMS 734448) on 2026-07-17 and posted it publicly on fda.gov on 2026-07-21.
- Is the FDA warning letter to mkpodplug.co.uk publicly available?
- Yes. The full verbatim letter is published at fda.gov. Argus HQ links directly to the source: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/mkpodplugcouk-734448-07172026.
- What does a "critical" severity rating mean for this letter?
- Critical severity. Typically reserved for data integrity, sterile-product CGMP, or repeat violations — matters that historically precede injunctions, consent decrees, or import alerts.
argus.hq
Don’t find out about the next one six weeks late.
Argus reads every FDA Warning Letter the day it publishes, summarizes it against your watchlist, and lands the ones touching your business in your inbox at 6am ET. Plans from $99/month. Cancel any time.
methodology
The analysis above is produced by Anthropic Claude Haiku 4.5 against the verbatim FDA Warning Letter excerpt and is brand-voice lint-checked before publish. The TL;DR is the same summary that ships in the customer email digest. Severity is auto-classified by Argus from the subject string and letter body using rules documented in lib/ingestion/fda-warning-letters.ts.
Argus HQ is informational only. Summaries and analyses are AI-generated and may contain errors, misclassifications, or omissions. Verify against the FDA source URL above. Argus HQ is not a law firm, accounting firm, or regulatory agency, and provides no legal, accounting, financial, medical, or regulatory advice.
Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder
Cite this record
Reusing this data in reporting or research? Here’s a ready-made citation.
Argus HQ Research (2026). FDA Cites mkpodplug.co.uk in 2026-07-17 Warning Letter — Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded. Digital Empire Holdings LLC. Retrieved from https://argushq.ai/fda/warning-letter/fda-wl-mkpodplug-co-uk-2026-07-17-tobacco
"FDA Cites mkpodplug.co.uk in 2026-07-17 Warning Letter — Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded." Argus HQ Research, Digital Empire Holdings LLC, 2026, argushq.ai/fda/warning-letter/fda-wl-mkpodplug-co-uk-2026-07-17-tobacco.
Argus HQ Research. "FDA Cites mkpodplug.co.uk in 2026-07-17 Warning Letter — Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded." Digital Empire Holdings LLC. Accessed July 22, 2026. https://argushq.ai/fda/warning-letter/fda-wl-mkpodplug-co-uk-2026-07-17-tobacco.
@misc{argushq_argushq_ai_fda_warning_letter_fda_wl_mkpodplug_co_uk_2026_07_17_tobacco_2026,
title = {FDA Cites mkpodplug.co.uk in 2026-07-17 Warning Letter — Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded},
author = {{Argus HQ Research}},
year = {2026},
publisher = {Digital Empire Holdings LLC},
url = {https://argushq.ai/fda/warning-letter/fda-wl-mkpodplug-co-uk-2026-07-17-tobacco},
note = {Accessed: July 22, 2026}
}